The FDA has placed another clinical hold on a gene therapy for Duchenne muscular dystrophy developed by Solid Biosciences, pulverising its share price. The halt of the IGNITE DMD trial was prompted by ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

AUD/USD stays depressed near three-week troughs below 0.6500 in the Asian session, consolidating weekly losses. The risk-off market mood due to renewed US-China jitters on the AI trade front combined ...